The new research by Heriot-Watt University has identified a way of targeting an enzyme called EPAC1
News
SMC accepts oral therapy for relapsing multiple sclerosis
Janssen’s Ponvory accepted for use within NHS Scotland for adults RRMS patients
CN Bio inks COVID-19 research deal with iiCON
iiCON’s lead partner LSTM will independently validate CN Bio’s novel lung and lung-liver models
Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
Funding proceeds will be used to support ongoing trials of Gyroscopes investigational gene therapy GT005
NHS staff face spring deadline for mandatory COVID vaccination
The government is expected to announce that frontline staff in England will have to be fully vaccinated against COVID-19
Positive results for GSK’s anaemia drug daprodustat
Daprodustat is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development for anaemia due to chronic kidney disease
Opdivo plus chemo improves event-free survival in NSCLC patients
Detailed results from the CheckMate-816 trial will be shared at an upcoming medical conference
AZ announces US fast track designation for IL-5 inhibitor Fasenra
Designation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis
UK gov’t warns of Christmas COVID restrictions, push for booster vaccines
Around 60% of those eligible have received their booster vaccinations in the UK
Pfizer’s COVID-19 pill cuts hospitalisation/death risk by 89%
The trial evaluated the investigational medicine in non-hospitalised adult patients with COVID-19 who are at high-risk of progressing to severe illness
Novartis’ iptacopan hits endpoints in mid-stage study
Investigational treatment is being evaluated in patients with C3 glomerulopathy
NICE issues draft recommendation for new kidney disease treatment
Forxiga becomes the first new treatment option for CKD patients in nearly 20 years
Researchers find HPV vaccine cuts cervical cancer by 87%
The research paper, published in the Lancet and funded by Cancer Research UK, considered all cervical cancers diagnosed in England among women aged 20-64 between January 2006 and June 2019
UK approval for MSD/Ridgeback’s COVID-19 antiviral med
The antiviral medicine will be marketed with the trademark name Lagevrio in the UK
Guardant Health and Royal Marsden NHS Foundation Trust announce partnership
Partnership will establish an in-house liquid biopsy testing service, using Guardant Health’s proprietary digital sequencing platform
